Merck signs $610 million deal to acquire Caraway Therapeutics
LONDON, UK: Merck, a global leader in biopharmaceuticals, has announced that it has entered into a definitive agreement to acquire Caraway Therapeutics, Inc., a company...
Merck appoints Deborah H. Telman as General Counsel for Organon & Co
KENILWORTH: Merck, known as MSD outside the United States and Canada, announced the appointment of Deborah H. Telman as General Counsel for Organon & Co.,...
Merck to develop AnteoBind-activated Europium particle products
BRISBANE: AnteoTech Ltd has signed a non-binding Heads of Agreement with Merck to co-develop AnteoBind activated Europium particles for the rapidly growing global point of...